3-iodobenzylguanidine has been researched along with Cardiac Complex, Premature in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avogaro, A; Casara, D; Crepaldi, C; Dalla Volta, S; Erle, G; Fasoli, G; Marin, M; Mingardi, R; Palisi, M; Scognamiglio, R | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Cardiac Complex, Premature
| Article | Year |
|---|---|
Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Agonists; Adrenergic Fibers; Adult; Body Weight; Cardiac Complexes, Premature; Cardiac Output, Low; Cardiac Volume; Cardiomyopathies; Case-Control Studies; Diabetes Mellitus, Type 1; Dobutamine; Echocardiography; Electric Stimulation; Exercise; Female; Hand Strength; Heart Conduction System; Humans; Incidence; Linear Models; Male; Myocardial Contraction; Physical Exertion; Radionuclide Imaging; Radiopharmaceuticals; Rest; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 1998 |